Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
maria.aggelakopoulou@immonc.ox.ac.uk
maria.aggelakopoulou@ndm.ox.ac.uk

Research groups

Rational Vaccine Development- Borrow Group

Maria Aggelakopoulou

PhD

GSK Research Fellow, Junior Group Leader

Recent publications

Osteopontin Promotes Protective Antigenic Tolerance against Experimental Allergic Airway Disease.

Alissafi T. et al, (2018), Journal of immunology (Baltimore, Md. : 1950), 200, 1270 - 1282

ERβ-Dependent Direct Suppression of Human and Murine Th17 Cells and Treatment of Established Central Nervous System Autoimmunity by a Neurosteroid.

Aggelakopoulou M. et al, (2016), Journal of immunology (Baltimore, Md. : 1950), 197, 2598 - 2609

ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.

Aggelakopoulou M. et al, (2016), Journal of immunology (Baltimore, Md. : 1950), 196, 4947 - 4956

TIGIT Enhances Antigen-Specific Th2 Recall Responses and Allergic Disease.

Kourepini E. et al, (2016), Journal of immunology (Baltimore, Md. : 1950), 196, 3570 - 3580

Osteopontin expression by CD103- dendritic cells drives intestinal inflammation.

Kourepini E. et al, (2014), Proceedings of the National Academy of Sciences of the United States of America, 111, E856 - E865

More publications